Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × proto-oncogene protein c-fes-fps × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Lobular 1

Interventions

pembrolizumab 460 Carboplatin 327 Specimen Handling 325 Magnetic Resonance Spectroscopy 287 Cisplatin 286 Nivolumab 273 Cyclophosphamide 260 Paclitaxel 229 Radiotherapy 216 Biopsy 200 Gemcitabine 191 Bevacizumab 183 Dexamethasone 151 durvalumab 145 Rituximab 144 Capecitabine 137 atezolizumab 136 Oxaliplatin 136 Docetaxel 135 Fluorouracil 133 venetoclax 130 Ipilimumab 121 Drug Therapy 120 Etoposide 119 Doxorubicin 113 Prednisone 111 Lenalidomide 109 Radiosurgery 104 Leucovorin 98 Pemetrexed 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04252859 2025-05-18

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

University of Utah

Phase 2 Terminated

44 enrolled 15 charts

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡